Nepriklausoma sveikatos laboratorija, MB - financials and debts

Company age: 3 y. 4 mo.

Update

Nepriklausoma sveikatos laboratorija - Company finances

EUR
2023
From: 2023-06-08
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 19,517 2,420 -
Profit before tax -1,851 -3,247 2,919
Net profit -1,851 -3,247 2,919
Equity -1,351 -2,747 -1,679
Liabilities 12,350 10,245 10,913
Non-current assets 0 0 0
Current assets 10,999 7,498 9,234
Total assets 10,999 7,498 9,234
Financial indicators
Revenue change y/y - -87.6% -
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -16.8% -43.3% 31.6%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - - -
Profit margin Net profit margin. Shows the overall profitability of the company. -9.5% -134.2% -
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. -9.5% -134.2% -
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Nepriklausoma sveikatos laboratorija - Social security debts

From To Debt, €
2024-03-01 2024-03-31 64.50
2024-01-03 2024-01-31 58.63
2023-11-03 2023-11-30 58.63
2023-08-01 2023-08-31 58.63

Nepriklausoma sveikatos laboratorija - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.